These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 31866051

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Mononuclear phagocytes orchestrate prolyl hydroxylase inhibition-mediated renoprotection in chronic tubulointerstitial nephritis.
    Schley G, Klanke B, Kalucka J, Schatz V, Daniel C, Mayer M, Goppelt-Struebe M, Herrmann M, Thorsteinsdottir M, Palsson R, Beneke A, Katschinski DM, Burzlaff N, Eckardt KU, Weidemann A, Jantsch J, Willam C.
    Kidney Int; 2019 Aug; 96(2):378-396. PubMed ID: 31146971
    [Abstract] [Full Text] [Related]

  • 23. JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor.
    Fukui K, Shinozaki Y, Kobayashi H, Deai K, Yoshiuchi H, Matsui T, Matsuo A, Matsushita M, Tanaka T, Nangaku M.
    Eur J Pharmacol; 2019 Sep 15; 859():172532. PubMed ID: 31301309
    [Abstract] [Full Text] [Related]

  • 24. Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability.
    Wu M, Chen W, Miao M, Jin Q, Zhang S, Bai M, Fan J, Zhang Y, Zhang A, Jia Z, Huang S.
    Clin Sci (Lond); 2021 Jul 30; 135(14):1707-1726. PubMed ID: 34255035
    [Abstract] [Full Text] [Related]

  • 25. [Dynamic observation of enalapril on the expression of TGF-beta1, CTGF, Smad7 and alpha-SMA in rats with unilateral ureteral obstruction].
    Wang L, Ning W, Tao L, Wang L, Peng Z.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Mar 30; 34(3):252-8. PubMed ID: 19349682
    [Abstract] [Full Text] [Related]

  • 26. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
    Baba I, Egi Y, Utsumi H, Kakimoto T, Suzuki K.
    Mol Med Rep; 2015 Dec 30; 12(6):8010-20. PubMed ID: 26498136
    [Abstract] [Full Text] [Related]

  • 27. Up-regulation of HSP47 in the mouse kidneys with unilateral ureteral obstruction.
    Moriyama T, Kawada N, Ando A, Yamauchi A, Horio M, Nagata K, Imai E, Hori M.
    Kidney Int; 1998 Jul 30; 54(1):110-9. PubMed ID: 9648069
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats.
    Signore PE, Guo G, Wei Z, Zhang W, Lin A, Del Balzo U.
    PLoS One; 2021 Jul 30; 16(8):e0255022. PubMed ID: 34339435
    [Abstract] [Full Text] [Related]

  • 31. Hypoxia-inducible factor-prolyl hydroxylase inhibitor ameliorates myopathy in a mouse model of chronic kidney disease.
    Qian FY, Li ZL, Guo YD, Gao HC, Gu LH, Le K, Xie CM, Wang B, Zhang ZJ.
    Am J Physiol Renal Physiol; 2019 Nov 01; 317(5):F1265-F1273. PubMed ID: 31588798
    [Abstract] [Full Text] [Related]

  • 32. Effect of Kidney Function and Dialysis on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor.
    Groenendaal-van de Meent D, Kerbusch V, Kaspera R, Barroso-Fernandez B, Galletti P, Klein GK, den Adel M.
    Eur J Drug Metab Pharmacokinet; 2021 Jan 01; 46(1):141-153. PubMed ID: 33165773
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat (FG-4592) alleviates sepsis-induced acute lung injury.
    Han F, Wu G, Han S, Li Z, Jia Y, Bai L, Li X, Wang K, Yang F, Zhang J, Wang X, Guan H, Linlin S, Han J, Hu D.
    Respir Physiol Neurobiol; 2020 Oct 01; 281():103506. PubMed ID: 32726645
    [Abstract] [Full Text] [Related]

  • 35. Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice.
    Matsuo S, López-Guisa JM, Cai X, Okamura DM, Alpers CE, Bumgarner RE, Peters MA, Zhang G, Eddy AA.
    Kidney Int; 2005 Jun 01; 67(6):2221-38. PubMed ID: 15882265
    [Abstract] [Full Text] [Related]

  • 36. Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling.
    Ji X, Wang H, Wu Z, Zhong X, Zhu M, Zhang Y, Tan R, Liu Y, Li J, Wang L.
    Med Sci Monit; 2018 Mar 20; 24():1633-1641. PubMed ID: 29555895
    [Abstract] [Full Text] [Related]

  • 37. The preventive and therapeutic implication for renal fibrosis by targetting TGF-β/Smad3 signaling.
    Zhang Y, Meng XM, Huang XR, Lan HY.
    Clin Sci (Lond); 2018 Jul 16; 132(13):1403-1415. PubMed ID: 29875262
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prolyl-4-Hydroxylases Inhibitor Stabilizes HIF-1α and Increases Mitophagy to Reduce Cell Death After Experimental Retinal Detachment.
    Liu H, Zhu H, Li T, Zhang P, Wang N, Sun X.
    Invest Ophthalmol Vis Sci; 2016 Apr 16; 57(4):1807-15. PubMed ID: 27082295
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.